The American Heart Association has released new cholesterol guidelines recommending earlier screening and treatment for ...

Lipid-lowering therapy can be considered with a 10-year PREVENT-ASCVD risk estimate of 3% to <5% (borderline) and should be considered for those at 5% to <10% (intermediate) 10-year risk. For ...

The AHA urges doctors to begin screening and treating patients who are still in their 30s, well before the risks of a heart attack and stroke are higher.

Heart health experts released new guidance to help identify early risk factors for heart disease that go beyond tracking ...